サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1136875

飼料用抗酸菌剤の世界市場-2022-2029

Global Feed Anticcocidials Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 170 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
飼料用抗酸菌剤の世界市場-2022-2029
出版日: 2022年10月13日
発行: DataM Intelligence
ページ情報: 英文 170 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

鶏肉やその他の動物に対する消費者の意識の高まり

国民の消費パターンや食生活に様々な変化が見られ、その結果、鶏肉の消費量が増加する傾向にあります。さらに、動物の健康の重要性に関する意識を広めるために、政府によってさまざまな動物健康意識向上キャンペーンが開始されています。飼料用抗酸菌剤は、動物の腸内環境と免疫の維持に大きな役割を果たすため、非常に注目されています。副作用がほとんどない天然の飼料添加物への需要が高まっています。この結果、主に養鶏業者の間で需要が増加しています。これに伴い、動物製品別の消費に関連する慢性疾患の発生率も上昇し、動物飼料用抗酸菌剤市場も拡大します。乾燥剤は、家禽類などの動物用飼料に混ぜて使用されます。また、乾燥剤は飼料に混ぜて使用されるため、一般的にほとんどの店舗で販売されています。コクシジウム症とは、腸内にコクシジウムが侵入することで発症する病気です。コクシジウム症は、家禽類における深刻な病気であり、家禽産業を経済的に混乱させる能力を持っているため、その発生を完全に防止するために、適切な管理策を講じる必要があります。予防と治療のための抗コクシジウム剤の使用と健全な飼育システムが、家禽のコクシジウム症を抑制するための第一条件です。

世界の飼料用抗酸菌剤市場レポートでは、約61の市場データ表、45の図、170ページへのアクセスを提供します。

目次

第1章 調査手法と範囲

  • 調査手法
  • 市場の範囲

第2章 主な動向と発展

第3章 エグゼクティブサマリー

  • 形態別市場内訳
  • タイプ別市場内訳
  • 家畜別市場内訳
  • 投与経路別市場内訳
  • 地域別市場内訳

第4章 市場力学

  • 市場影響要因
    • 促進要因
    • 抑制要因
    • ビジネスチャンス
  • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 特許分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み

第7章 形態別

  • ドライ
  • 液体

第8章 投与経路別

  • 経口
  • 注射

第9章 タイプ別

  • モネンシン
  • ラサロシド
  • サリノマイシン
  • ニカルバジン
  • ジクラズリル
  • その他

第10章 畜産物別

  • 家禽類
  • 豚
  • 反芻動物
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 競合シナリオ
  • 競合他社の戦略分析
  • 市況/シェア分析
  • M&A（合併・買収）分析

第13章 企業プロファイル

  • Elanco Animal Health
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Huvepharma
  • Phibro Animal Health
  • Ceva Animal Health.
  • Zoetis
  • Kemin Industries
  • Merck Animal Health
  • Virbac SA
  • Zydus Animal Health
  • Bioproperties Pty. Ltd.

第14章 DataM

目次
Product Code: DMAG5897

Market Overview

Feed Anticoccidials Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 4.89% during the forecast period (2022-2029).

Feed anticoccidials are used to treat coccidials in poultry and other animals and widely used as an additive in feed and veterinary drugs. These are active substances which belong to the group of polyether ionophore antibiotics and are produced by streptomyces albus. The coccidia are responsible for major economic losses of the livestock industry as coccidiosis is an infectious disease of the intestinal tract of wild and domestic animals caused by different protozoa. Some of the control measures include good husbandry as a prime requirement and the use of anticoccidial drugs for prophylaxis and treatment. The protozoan type parasites live and multiply in the intestinal tract and cause tissue damage resulting damage interferes with food digestion and nutrient absorption. For the drug to be effective anticoccidial, it should be used prophylactically instead of therapeutically and the early control measures should be followed for the prevention. Increasing demand for natural feed anticoccidials, due to rising consumer awareness provides a huge market opportunity for the key players operating in the feed anticoccidials market.

Market Dynamics: Rising consumer awareness towards the poultries and other animals

Various changes have been witnessed regarding the consumption patterns and dietary habits of the population due to which there has been a shift towards the increased consumption of poultry. Furthermore, various animal health awareness campaigns are also initiated by the government to spread awareness about the importance of animal health. Feed anticoccidials have witnessed huge attention as it plays a major role in maintaining the gut health and immunity of animals. There is an increase in the demand for natural animal feed additives, which have negligible side effects. This results in the rise in demand majorly among poultry farmers. With this, the rising incidence of chronic diseases associated with the consumption of animal by-products also increases the animal feed anticoccidials market. The dry form is mixed in the feed for animals including poultry and others. Also, the dry form is generally available in almost all the stores, as it is mixed with the feed. It occurs owing to the infestation of coccidia in the intestines. Coccidiosis is still a severe disease in poultry, also having the ability to disrupt the poultry industry economically due to which proper control measures need to be followed for the complete prevention of its occurrence. Usage of anticoccidial drugs for both prophylaxis and treatment and sound husbandry systems are primary requirements to curb coccidiosis in poultry.

Market Segmentation: Oral segment accounted for the highest share in global feed anticoccidials market

In 2021, the oral segment dominated the market, accounting for YY% of global sales as it is widely used in dietary supplements. Due to widespread emergence of antimicrobial resistance, concerns have been raised regarding the safety of anticoccidials and the potential impact on animal resulting in the use of oral drugs. The intestinal damage caused by the disease results in decreased feed intake and retarded growth as well as suppression of cell-mediated immune response and low survival, all of which have significant adverse implications for the commercial poultry. Anticoccidial drugs added to the feed constitute a good preventative measure and are convenient for large-scale use due to which these drugs are widely used to prevent the disease. Scientific evidence has shown that these supplements are used to optimize the health of animals by positive manipulation of the gastrointestinal tract as these drugs are based on the antimicrobial mode of action.

Geographical Penetration: APAC is the dominating region during the forecast period

APAC is projected to be the dominating region due to the enormous presence of domesticated animals in the developing countries such as China, Japan and other countries. Increasing awareness about animal health and growing health expenditure, especially in India and China has driven the demand in this region. China and India also saw significant increases in livestock breeding for meat and poultry products. According to the National Poultry Newspaper, poultry requires 60 percent protein, 13 percent fat and 3 percent calcium, the required nutrient content is met majorly by poultry by-products and fish meal and these byproducts are available as a feed source. The demand has increased from 119,205.21 metric ton in 2018 to 120,884.63 metric ton in 2019 for the poultries. Higher levels of production are associated with the spread of intensive systems in which food conversion ratios are high which has increased the share of Chinas total livestock production. According to Depart of Animal Husbandry and Dairying, contribution from poultry meat sector was contributed to be 75.32% and poultry egg sector contributed to be 24.67% in India. In addition, the annual production of poultry meat was 4.06 metric tons in the year 2018-2019. All these factors have propelled the demand for the market.

Competitive Landscape:

There are several established participants in the industry and local manufacturers; hence, the market is fragmented. Some major key players are Elanco Animal Health, Ceva Animal Health, Zoetis, Phibro Animal Health, Kemin Industries, Merck Animal Health, Virbac SA, Zydus Animal Health, Bioproperties Pty. Ltd., Huvepharma, Qilu Animal Health Products among others. Some of the major key players invested in expanding their business along. For instance, in March 2021, Eloancoanimal health Inc., launched "zoasheild,clinacox, and cosabody are the three major launches of feed anticoccidials in the year 2021. Through these products the company expanded its product portfolio along which is the three antibiotic alternative intestinal integrity products. This portfolio expansion allows Elanco to better serve Raised Without Antibiotics (RWA) customers and provides a broader suite of solutions to both conventional poultry producers and turkey producers looking for coccidiosis control as this disease of the top producers. In 2020, Huvepharma launched "Monimax" which is EU approved coccidiosis control product. The product can be sold across Europe and in countries that require this certificate, including important global markets like Thailand and Turkey.

COVID-19 Impact: Negative impact on the global feed anticoccidials market

The initial COVID-19 lockdown caused disruptions in the logistics system and affected the supply of poultry feed across the globe. There had been restrictions and shutdown of poultry feed companies across the globe in the initial phase, which in turn resulted in the shortage of feed for livestock farmers. The sales of edible products such as poultry, meat products, and many others were up to the mark as the supply of food products was insufficient as many of the manufacturers have shut operations due to shortage of labors along with the mass production shutdowns and supply chain disruptions. Shutting down of supermarkets and shops due to COVID-19 lockdown restrictions which has significantly impacted the product revenues. Some of the other reasons which led to decrease in sales of feed anticoccidials food during the pandemic are the high dependence on self-made vegetarian food due to the fear of COVID-19 virus and lockdown which forced people not to move out of their houses.

The global feed anticoccidials market report would provide an access to approximately 61 market data tables, 45 figures and 170 pages

Table of Contents

1. Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Form
  • 3.2. Market Snippet by Type
  • 3.3. Market Snippet by Livestock
  • 3.4. Market Snippet by Route of Administration
  • 3.5. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Form

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Form Segment
    • 7.1.2. Market attractiveness index, By Form Segment
  • 7.2. Dry*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Liquid

8. By Route of Administration

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Route of Administration Segment
    • 8.1.2. Market attractiveness index, By Route of Administration Segment
  • 8.2. Oral*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Injection

9. By Type

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By Type Segment
    • 9.1.2. Market attractiveness index, By Type Segment
  • 9.2. Monensin*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 9.3. Lasalocid
  • 9.4. Salinomycin
  • 9.5. Nicarbazin
  • 9.6. Diclazuril
  • 9.7. Others

10. By Livestock

  • 10.1. Introduction
    • 10.1.1. Market size analysis, and y-o-y growth analysis (%), By Livestock Segment
    • 10.1.2. Market attractiveness index, By Livestock Segment
  • 10.2. Poultry*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 10.3. Swine
  • 10.4. Ruminant
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key region-specific dynamics
    • 11.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Route of Administration
    • 11.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Livestock
    • 11.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.2.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. South America
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Route of Administration
    • 11.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Livestock
    • 11.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.3.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.3.7.1. Brazil
      • 11.3.7.2. Argentina
      • 11.3.7.3. Rest of South America
  • 11.4. Europe
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Route of Administration
    • 11.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Livestock
    • 11.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.4.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.4.7.1. Germany
      • 11.4.7.2. U.K.
      • 11.4.7.3. France
      • 11.4.7.4. Spain
      • 11.4.7.5. Italy
      • 11.4.7.6. Rest of Europe
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Route of Administration
    • 11.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Livestock
    • 11.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 11.5.7. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Form
    • 11.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Route of Administration
    • 11.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Livestock
    • 11.6.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type

12. Competitive Landscape

  • 12.1. Competitive scenario
  • 12.2. Competitor strategy analysis
  • 12.3. Market positioning/share analysis
  • 12.4. Mergers and acquisitions analysis

13. Company Profiles

  • 13.1. Elanco Animal Health*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Huvepharma
  • 13.3. Phibro Animal Health
  • 13.4. Ceva Animal Health.
  • 13.5. Zoetis
  • 13.6. Kemin Industries
  • 13.7. Merck Animal Health
  • 13.8. Virbac SA
  • 13.9. Zydus Animal Health
  • 13.10. Bioproperties Pty. Ltd.
  • List not Exhaustive*

14. DataM

  • 14.1. Appendix
  • 14.2. About us and services
  • 14.3. Contact us